Table 1.
Vaccine | Sponsor | Vaccine type | Some of the trials listed | Approval |
---|---|---|---|---|
Covovax (Novavaz formulation) | Serum Institute of India | Protein subunit |
• CTRI/2022/04/042017 • CTRI/2021/02/031554 |
Bangladesh, India, Indonesia, Philippines, Thailand |
Corbevax (BECOV2A) | Biological E limited | Protein subunit |
• CTRI/2021/08/036074 • CTRI/2021/10/037066 • CTRI/2021/06/034014 • CTRI/2020/11/029032 |
Botswana, India |
ZyCoV-D | Zydus Cadila | DNA |
• CTRI/2021/01/030416 • CTRI/2022/06/043365 • CTRI/2020/07/026352 • CTRI/2021/03/032051 |
India |
GEMCOVAC-19 | Gennova Biopharmaceuticals | RNA | • CTRI/2022/04/041880 | India |
Spikevax | Moderna | RNA |
• NCT05230953 etc |
88 countries including India |
iNCOVACC | Bharat Biotech | Non replicating viral vector |
• CTRI/2022/02/040065 |
India |
Sputnik Light | Gamaleya | Non replicating viral vector |
• CTRI/2022/04/041792 |
26 countries including India |
Sputnik V | Gamaleya | Non replicating viral vector | 74 countries including India | |
Jcovden | Johnson & Johnson | Non replicating viral vector | 113 countries including India | |
Vaxzevria | Oxford/Astrazeneca | Non replicating viral vector |
• jRCT2031210679 |
149 countries including India |
Covishield | Serum Institute of India | Non replicating viral vector |
• CTRI/2022/04/042017 • CTRI/2022/04/041792 • CTRI/2020/08/027170 |
49 countries including India |
Covaxin | Bharat biotech | Inactivated virus |
• CTRI/2022/04/042017 • CTRI/2022/04/041792 |
14 countries including India |